x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Psychopharmacology and Psychiatry Updates

Psychopharmacology Institute

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

health & fitness medicine

All Episodes

10:28

The Prevalence and Risks of RBD

Psychopharmacology and Psychiatry Updates ·

2023/08/25

In this episode, we dive into rapid eye movement sleep behavior disorder (RBD). Did you know that RBD's prevalence is on par with schizophrenia in middle-aged and older adults? Tune in as we explore the prevalence, assessment, and management of RBD, a condition that is not only a sleep disorder but a potential harbinger of severe neurological conditions, like Parkinson's Disease and Dementia with Lewy Bodies. Faculty: Carlos Schenck, M.D. Host: Richard Seeber, M.D. Learn more about our memberships

en

09:48

ADHD Medication and Their Role in Anxiety and Depression

Psychopharmacology and Psychiatry Updates ·

2023/08/20

In this episode, we dive deep into the effects of ADHD medication on anxiety and depressive symptoms in children and adolescents. Can these medications significantly exacerbate symptoms of anxiety or depression? Or do these symptoms arise more from the underlying condition of ADHD? We will delve into these critical questions and more through a thorough exploration of a comprehensive meta-analysis. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn

en

08:38

In the Realm of Sleep: RBD Diagnosis Explained

Psychopharmacology and Psychiatry Updates ·

2023/08/15

In this episode, we delve deep into the diagnostic mysteries of RBD, the need for video polysomnography, and the mechanisms leading to RBD. Whether you are a veteran or new to the field, this episode promises to deepen your understanding of RBD. Faculty: Carlos Schenck, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Parasomnias Triggered by Antidepressant Medications: REM Sleep Behavior Disorder and Restless Legs Syndrome Diagnosing REM Sleep Behavior

en

08:14

NAC in Schizophrenia: Pie in the Sky or...

Psychopharmacology and Psychiatry Updates ·

2023/08/10

Are we missing a vital piece in the schizophrenia treatment puzzle? In this episode, we explore the intriguing and controversial role of N-acetylcysteine (NAC) in schizophrenia. We dive deep into the evidence, the theories, and the ongoing debates about this seemingly simple over-the-counter supplement. Could NAC be the key to unlocking better outcomes for those with schizophrenia, or is it just another dead end? Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership

en

07:21

Child Psychiatry: NAC and SAMe

Psychopharmacology and Psychiatry Updates ·

2023/08/05

How can N-acetyl cysteine (NAC) and S-adenosyl methionine (SAMe) be effectively integrated into child and adolescent psychiatric treatment? In this episode, we dive deep into the world of NAC and SAMe and explore their potential applications, dosage, side effects, and more. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Natural Medications in Child and Adolescent Psychiatry Administration of N-Acetylcysteine and S-Adenosylmethionine in

en

08:17

Youth Psychotropic Prescription Trends: Pandemic...

Psychopharmacology and Psychiatry Updates ·

2023/07/31

How has the use of antipsychotics among children and adolescents been affected by the COVID-19 pandemic in the United States? In this episode, we delve into pandemic-induced trends in youth psychotropic prescriptions. Uncover how COVID-19 reshaped mental health services and psychopharmacology among young individuals. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 07 Psychotropic Prescriptions in Youth During

en

13:02

Nature's Remedies in Youth: St. John's Wort and Valerian

Psychopharmacology and Psychiatry Updates ·

2023/07/26

Can nature’s remedies hold the key to mental well-being in our youth? In this episode, we delve into the potential uses and limitations of St. John’s wort and valerian in child and adolescent psychiatry and, most importantly, their evidence in treating psychiatric disorders in this population. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Natural Medications in Child and Adolescent Psychiatry St. John’s Wort and Valerian: Potential

en

10:20

Exploring Serotonergic Antidepressants for PMDD

Psychopharmacology and Psychiatry Updates ·

2023/07/21

Have you ever pondered the mystery behind the effectiveness of different SSRI dosing strategies for premenstrual dysphoric disorder (PMDD)? In this episode, we delve deep into the complex world of PMDD treatments, focusing on the intriguing comparison between intermittent luteal phase dosing and continuous dosing of serotonergic antidepressants. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 46 Intermittent Selective

en

14:33

Exploring Omega-3's Role in Child Psychiatry

Psychopharmacology and Psychiatry Updates ·

2023/07/16

Have you ever wondered how natural remedies like omega-3 fatty acids might influence child and adolescent psychiatry? In this episode, we delve into the intriguing world of omega-3 fatty acids and their potential role in treating various psychiatric disorders in children and adolescents, such as major depressive disorder, bipolar disorder, ADHD, and ASD. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Natural Medications in Child and

en

08:15

ADHD Meds for Preschoolers: Lisdexamfetamine

Psychopharmacology and Psychiatry Updates ·

2023/07/11

Have you ever wondered about the safety and effectiveness of ADHD medications in preschoolers? In this episode, we discuss a pioneering double-blind, fixed-dose study exploring the use of lisdexamfetamine in children aged 4–5 years. We delve into the nuances of this complex topic, from the increasing trend of psychotropic medication use in young children, to the unique characteristics that distinguish lisdexamfetamine from other amphetamine medications. Faculty: David Rosenberg, M.D. Host: Richard

en

09:30

Using Ginkgo Biloba in Children

Psychopharmacology and Psychiatry Updates ·

2023/07/06

In this episode, we delve into the intriguing world of ginkgo biloba and its potential role in treating ADHD in children and adolescents. Can this ancient herbal remedy offer a valuable alternative or adjunctive therapy? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Natural Medications in Child and Adolescent Psychiatry Use of Ginkgo Biloba in Children and Adolescents

en

09:12

Examining COVID's Lasting Effects in Psychiatry

Psychopharmacology and Psychiatry Updates ·

2023/07/01

In this episode, we delve into the intriguing world of COVID-19's long-term effects in psychiatry. We explore a groundbreaking study that examines the duration of COVID-associated psychiatric disorders and variations in susceptibility by age. How long do these disorders persist, and are certain age groups more affected? Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 46 Neurologic and Psychiatric Risk Trajectories After

en

11:00

Beyond SSRIs: Antipsychotic Augmentation in OCD

Psychopharmacology and Psychiatry Updates ·

2023/06/26

In this episode, you'll discover the preferred second-generation antipsychotics for augmenting treatment for obsessive-compulsive disorder: Risperidone and aripiprazole. We discuss their effectiveness and important considerations when choosing between them. What factors should clinicians weigh when deciding on an augmentation strategy? Faculty: David Osser, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Algorithm for the Pharmacotherapy of Obsessive-Compulsive

en

11:15

Overcoming Barriers to Metabolic Monitoring in Youth...

Psychopharmacology and Psychiatry Updates ·

2023/06/21

In this episode, we focus on the challenges faced in metabolic monitoring of youth receiving second-generation antipsychotics (SGAs), including the strategies to overcome these barriers and ensure the long-term health of young patients on SGAs. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 06 Barriers to Metabolic Monitoring of SGAs in Youth

en

11:56

Exploring Outcomes and Strategies in OCD Treatment...

Psychopharmacology and Psychiatry Updates ·

2023/06/16

In this episode, we delve into the potential outcomes after the first SSRI trial for OCD. With SSRIs being a first-line treatment, understanding response patterns is crucial. What course of action should be taken when patients exhibit significant symptom improvement, partial relief, or no response? Discover when to discontinue, switch, or augment treatment. Faculty: David Osser, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Algorithm for the Pharmacotherapy of

en

16:43

Diving Into the APA Annual Meeting: Highlights and...

Psychopharmacology and Psychiatry Updates ·

2023/06/11

In this episode, Dr. Richard Seeber and his special guests, Dr. Lorena Rodriguez and Dr. Paz Badia, discuss the topics covered in the APA Annual Meeting 2023, from technology in mental health practice to the use of cognitive–behavioral therapy for suicide prevention. Get ready to explore topics like ECT, ADHD, women's health, and much more. How can the integration of technology revolutionize mental health practice? Faculty: Paz Badia, M.D. and Lorena Rodríguez, M.D. Host: Richard Seeber, M.D. Learn

en

09:01

Exploring the Intriguing World of Microdosing Psilocybin

Psychopharmacology and Psychiatry Updates ·

2023/06/06

In this episode, we delve into the fascinating world of microdosing psilocybin. A recent randomized trial examined the effects of microdosing using various outcome measures. Surprisingly, the acute effects were significantly more intense for the active dose but only when participants correctly identified their experimental condition. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 45 Microdosing With Psilocybin Mushrooms: A

en

11:11

SSRIs for OCD: A Closer Look at First-Line Treatment

Psychopharmacology and Psychiatry Updates ·

2023/06/01

What factors should clinicians consider when choosing an SSRI for treating patients with OCD? In this episode, we dive into the first-line treatment for OCD: SSRIs. Discover the most effective SSRIs for treating OCD, recommended doses, and potential adverse effects. Faculty: David Osser, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Algorithm for the Pharmacotherapy of Obsessive-Compulsive Disorder Node 2: First-Line Treatment: SSRIs

en

10:16

Exploring Nonstimulant Treatments for ADHD

Psychopharmacology and Psychiatry Updates ·

2023/05/27

Are there any particular situations where nonstimulant medications may be especially effective for ADHD? In this episode, we discuss nonstimulant treatments for ADHD. Although stimulants are commonly used for ADHD, nonstimulant options like atomoxetine, viloxazine, clonidine, and guanfacine have been FDA approved and can be equally effective in certain populations. Listen in as we share clinical pearls on how to tailor treatments for each patient's unique needs. Faculty: David Rosenberg, M.D. Host:

en

10:17

Complexities of OCD Treatment: Comorbidities and...

Psychopharmacology and Psychiatry Updates ·

2023/05/22

In this episode, we share insights into the comorbidities and other considerations that can impact the treatment algorithm for OCD. From the risks of medication use in pregnant women, to the challenges of treating OCD in patients with comorbid bipolar disorder, this episode provides valuable clinical pearls for clinicians looking to improve their approach to treating OCD. Faculty: David Osser, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Algorithm for the

en

431 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown